WallStSmart
ENTX

Entera Bio Ltd

NASDAQ: ENTX · HEALTHCARE · BIOTECHNOLOGY

$1.19
+6.25% today

Updated 2026-04-30

Market cap
$60.98M
P/E ratio
P/S ratio
1,452.00x
EPS (TTM)
$-0.25
Dividend yield
52W range
$1 – $3
Volume
0.2M

Entera Bio Ltd (ENTX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$500000.00$236000.00$365000.00$571000.00$134000.00$14000.00$181000.00$42000.00
Revenue growth (YoY)-52.8%+54.7%+56.4%-76.5%-89.6%+1192.9%-76.8%
Cost of revenue$28000.00$35000.00$43000.00$0.00$448000.00$209000.00$373000.00$101000.00$56000.00$172000.00$72000.00
Gross profit$-28000.00$-35000.00$-43000.00$500000.00$-212000.00$156000.00$198000.00$33000.00$-56000.00$9000.00$-30000.00
Gross margin100.0%-89.8%42.7%34.7%24.6%-400.0%5.0%-71.4%
R&D$2.12M$2.65M$2.77M$8.52M$6.96M$6.40M$6.77M$5.85M$4.45M$4.50M$6.00M
SG&A$1.59M$2.72M$8.57M$2.84M$4.28M$4.89M$5.69M$7.25M$4.43M$5.09M$5.53M
Operating income$-3.70M$-5.37M$11.34M$-10.86M$-11.45M$-11.13M$-12.22M$-13.02M$-8.94M$-9.59M$-11.53M
Operating margin-2172.2%-4853.4%-3050.1%-2139.6%-9714.2%-63857.1%-5295.6%-27450.0%
EBITDA$-3.67M$-5.33M$-11.05M$-10.81M$-10.47M$-10.91M$-12.16M$-12.95M$-8.80M$-9.54M$-11.50M
EBITDA margin-2161.4%-4437.7%-2988.5%-2130.3%-9666.4%-62885.7%-5270.2%-27378.6%
EBIT$-3.70M$-5.37M$-11.09M$-10.86M$-10.71M$-11.13M$-12.22M$-13.02M$-8.86M$-9.59M$-11.53M
Interest expense$0.00$0.00$0.00$0.00$84000.00$1.40M$29000.00$26.00M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-4.28M$-1.20M$-11.20M$-10.30M$-10.79M$-9.98M$-12.19M$-13.07M$-8.89M$-9.54M$-11.44M
Net income growth (YoY)+72.0%-833.9%+8.0%-4.8%+7.5%-22.1%-7.3%+32.0%-7.3%-19.9%
Profit margin-2060.8%-4574.2%-2735.1%-2134.3%-9754.5%-63492.9%-5271.3%-27235.7%